Search clinical trials for: calcium sensing receptor,
Total 24427 results
-
Corcept TherapeuticsCompleted
-
VA Office of Research and DevelopmentUniversity of PennsylvaniaWithdrawn
-
Taisho Pharmaceutical R&D Inc.Yale UniversityCompleted
-
MallinckrodtTerminated
-
HRA PharmaCompletedContraception | Gynecologic DiseasesFrance, Belgium
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)TerminatedGraft Versus Host Disease | Hematopoietic Cell Transplantation RecipientUnited States
-
GlaxoSmithKlineWithdrawnHormone-receptor Positive Breast CancerUnited States
-
Chembrain LTDUniversity of Oulu; Jyväskylä Central Hospital; Apollo Hospital, New Delhi, IndiaActive, not recruitingGlioblastoma | Glioblastoma Multiforme | Glioma, MalignantFinland, India
-
Immunicom IncRecruitingNon Small Cell Lung CancerTurkey
-
Charite University, Berlin, GermanyNeuroCure Clinical Research Center, Charite, BerlinCompletedMajor DepressionGermany
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.RecruitingEarly-stage Breast Cancer | Breast Cancer Invasive | HER2 Low Breast Carcinoma | Hormone-receptor-positive Breast CancerChina
-
Peking University First HospitalCompletedBreast Cancer | Predictive Value of Tests | Neoadjuvant Therapy | Prognosis | HER2 | Neoplasm Staging | Estrogen Receptor | Histological GradeChina
-
Elpiscience Biopharma Australia Pty. Ltd.RecruitingAdvanced Solid TumorAustralia
-
University of Wisconsin, MadisonNot yet recruitingNeuroendocrine Tumors | Somatostatin Receptor-positive Neuroendocrine TumorUnited States
-
Corcept TherapeuticsCompletedMetastatic Castration-Resistant Prostate CancerUnited States, United Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteKite, A Gilead CompanyRecruitingLarge B-cell Lymphoma | Relapsed Non-Hodgkin LymphomaUnited States
-
Fudan UniversityNot yet recruitingAdvanced Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone-receptor-positive Breast CancerChina
-
Aragon Pharmaceuticals, Inc.Completed
-
Beijing Tsinghua Chang Gung HospitalBeijing DCTY® Biotech Co.,Ltd.Not yet recruiting
-
Mayo ClinicNational Cancer Institute (NCI)CompletedStage IV Skin Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage IIA Skin Melanoma | Stage IIB Skin Melanoma | Stage IIC Skin Melanoma | Stage IIIA Skin MelanomaUnited States
-
Coordinación de Investigación en Salud, MexicoHospital Infantil de Mexico Federico GomezCompleted
-
Joyce Marie SlingerlandStanford UniversityCompleted
-
Buddhist Tzu Chi General HospitalCompletedSpinal Cord InjuriesTaiwan
-
Ahon Pharmaceutical Co., Ltd.RecruitingAdvanced Breast Cancer | Female Breast CancerChina
-
Ronald M Burch MD PhDCompletedMajor Depressive Disorder
-
H. Lee Moffitt Cancer Center and Research InstituteAstraZenecaTerminatedBreast Cancer | Hormone Receptor Positive TumorUnited States
-
National Cancer Institute (NCI)CompletedProstatic Neoplasms | Prostate Cancer | Neoplasms of Prostate | Cancer Of Prostate | Stage D0 Prostate CancerUnited States
-
University of NebraskaRecruitingClinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine TherapyBreast CancerUnited States
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompletedLeiomyosarcomaUnited States
-
AnaptysBio, Inc.Recruiting
-
Lund UniversityFerring PharmaceuticalsCompleted
-
R-PharmAlmedisCompleted
-
Aristotle University Of ThessalonikiUniversity of AthensSuspended
-
Starkey Laboratories, IncCompletedHearing Loss | Hearing Loss, SensorineuralUnited States
-
Armgo Pharma, Inc.Food and Drug Administration (FDA)RecruitingCatecholaminergic Polymorphic Ventricular Tachycardia Type 1United States, Netherlands
-
Tufts UniversityNational Institute on Aging (NIA); Boston Medical CenterCompletedSarcopenia | FallsUnited States
-
University Medical Center GroningenTerminatedPostmenopausal | Psychiatric/Mood Disorder | Patient | Estrogen Receptor Levels | PremenopausalNetherlands
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)RecruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | HER2/Neu Negative | Estrogen Receptor and/or Progesterone Receptor PositiveUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCUnknownStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Stage III Breast CancerUnited States
-
EnhancedBio USA Inc.ZenopharmRecruitingMetastatic Breast Cancer | Locally Advanced Breast Cancer | HER2-Negative | Estrogen Receptor-PositiveUnited States, Korea, Republic of
-
University of California, San FranciscoDana-Farber Cancer Institute; Translational Breast Cancer Research ConsortiumCompletedMetastatic Breast Cancer | Hormone Receptor PositiveUnited States
-
University Hospital, Gentofte, CopenhagenCompleted
-
University of CambridgeCompletedCardiovascular DiseaseUnited Kingdom
-
Ralph NULL SalloumChildren's Hospital Medical Center, CincinnatiRecruitingHigh Grade Glioma | Medulloblastoma | Meningioma | Anaplastic Ependymoma | Recurrent Malignant Glioma | Recurrent Medulloblastoma | Refractory Malignant Glioma | Refractory Medulloblastoma | Recurrent Diffuse Intrinsic Pontine Glioma | Recurrent Primary Central Nervous System Neoplasm | Refractory Primary... and other conditionsUnited States
-
Assistance Publique Hopitaux De MarseilleRecruiting
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)CompletedCannabis Dependence, Continuous | Cannabis Use DisorderUnited States
-
Maidstone & Tunbridge Wells NHS TrustUniversity of KentUnknown
-
National Taiwan University HospitalDaiichi Sankyo Taiwan Ltd.CompletedExercise Training | Vascular FunctionTaiwan
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingEdema | Erythema | Breast Carcinoma | Invasive Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Inflammatory Breast Carcinoma | Breast Lump | Peau d'OrangeUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States